Thyroid Artery Embolization for the Treatment of Compressive Goiters.

Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy of TAE for compressive symptoms of nodular goiters. Not only to corroborate current emerging results but clearly define the expected results for this technique.

Trial Details

NCT ID
NCT07360587
Phase
NA
Sponsor
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Thyroid Artery Embolization
Locations (sample)
  • Sherbrooke, Quebec, Canada|45.40008,-71.89908

Key Eligibility Criteria

  • Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND
  • Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND
  • TiRADS category 1, 2, 3 or 4 AND
  • Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →